Showing 1,021 - 1,040 results of 81,669 for search '(( 50 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 2 we decrease ))', query time: 1.34s Refine Results
  1. 1021
  2. 1022
  3. 1023

    Image_2_Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells.tiff by Daniel Feinberg (12395563)

    Published 2022
    “…Chemical inhibition of O-GlcNAcylation using OSMI-1 was associated with a decreased expression of NK cell receptors (NKG2D, NKG2A, NKp44), cytokines [tumor necrosis factor (TNF)-α, interferon (IFN-γ)], granulysin, soluble Fas ligand, perforin, and granzyme B in NK cells. …”
  4. 1024
  5. 1025
  6. 1026

    SFN decreased MMP-2 expression and activity in U87MG and U373MG cells. by Chunliu Li (284115)

    Published 2014
    “…<p>(A) SFN decreased MMP-2 expression via activated ERK1/2. We treated the cells with SFN (20 µM) without or with PD98059 (25 µM) for 24 h. …”
  7. 1027
  8. 1028

    DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

    Published 2020
    “…<i>daf-16</i> mutants are documented to have lowered locomotory ability vs. WT later in life [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref091" target="_blank">91</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.ref092" target="_blank">92</a>]; we note that, although comparison of scores across experiments is not possible due to variation in baseline values, the swimming rate of <i>daf-16(mgDf50)</i> control animals was slightly lower than WT controls on the same day of life (in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.g001" target="_blank">Fig 1C</a>; mean of 46.17 head thrashes/30 sec. for <i>daf-16</i> vs. 52.17 head thrashes/30 sec. for WT on day 10). …”
  9. 1029
  10. 1030
  11. 1031
  12. 1032

    Image_2_Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves’ Disease.tif by Ziyi Chen (458298)

    Published 2021
    “…To develop novel immunotherapies for pGD, we investigated the role of T cells in the long-lasting phase of GD. …”
  13. 1033
  14. 1034
  15. 1035
  16. 1036
  17. 1037
  18. 1038

    Disrupting Glycolysis-promoting Genes Extends <i>C</i>. <i>elegans</i> Healthspan, Whereas High Glucose and Gluconeogenic Gene Disruptions Shorten Healthspan. by Brian Onken (86790)

    Published 2020
    “…<i>elegans</i> ORF designations indicated). We note that, in our hands, disruption of C50F4.2 (<i>pfk-1</i>.…”
  19. 1039
  20. 1040